tobramycin has been researched along with Innate Inflammatory Response in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Birket, SE; Bollar, GE; Keith, JD; Kiedrowski, MR; Oden, AM | 1 |
| Larsson, A; Lipcsey, M; Maudsdotter, L; Sjölin, J; Skorup, P | 1 |
| Bradbury, P; Kassiou, M; Ong, HX; Pozzoli, M; Reekie, TA; Robinson, PD; Sheikh, Z; Traini, D; Young, PM | 1 |
| Castegren, M; Larsson, A; Lipcsey, M; Maudsdotter, L; Sjölin, J; Skorup, P; Tano, E | 1 |
| Alipour, M; Lui, EM; Omri, A; Suntres, ZE | 1 |
| Baldaniya, L; Gandhi, T; Gohel, M; Metalia, V; Patel, N; Thakkar, V | 1 |
| Banerjee, AR; Biswas, MC; Kundu, PK; Mandal, R; Mondal, A; Sasmal, NK | 1 |
| Comstock, TL; Holland, EJ | 1 |
| Passani, A; Passani, F; Pianini, V; Rossi, GC | 1 |
| Bjerner, J; Bjøro, T; Gaudernack, G; Holte, H; Høiby, EA; Kvalheim, G; Kvaløy, S; Mollnes, TE; Sandstad, B; Torfoss, D | 1 |
| Bateman, KM; Comstock, TL; Decory, HH; Gearinger, M; Paterno, MR | 1 |
| Ambrose, CG; Clyburn, TA; Gogola, GR; Mikos, AG; Peng, AS; Raymond, AK | 1 |
| Amin, D; Bertin, D; Cockrum, PC; Kennedy, M; Notivol, R; Whitling, A | 1 |
| Bennett, WM; Brummett, RE; Gilbert, DN; Houghton, DC; Kohlhepp, SJ; Kohnen, PW; Norton, DR; Porter, GA; Wood, CA | 1 |
1 review(s) available for tobramycin and Innate Inflammatory Response
| Article | Year |
|---|---|
Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens.
Topics: Administration, Topical; Androstadienes; Anti-Allergic Agents; Anti-Bacterial Agents; Drug Combinations; Eye Diseases; Humans; Inflammation; Intraocular Pressure; Loteprednol Etabonate; Ophthalmic Solutions; Tobramycin | 2010 |
4 trial(s) available for tobramycin and Innate Inflammatory Response
| Article | Year |
|---|---|
Efficacy and safety of netilmycin/dexamethasone preservative-free and tobramycin/dexamethasone-preserved fixed combination in patients after cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Dexamethasone; Drug Combinations; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Netilmicin; Pain, Postoperative; Phacoemulsification; Postoperative Complications; Prospective Studies; Single-Blind Method; Time Factors; Tobramycin | 2010 |
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cytokines; Female; Humans; Inflammation; Lymphoma; Male; Middle Aged; Neutropenia; Risk Factors; Tobramycin; Young Adult | 2011 |
Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects.
Topics: Androstadienes; Anti-Allergic Agents; Anti-Bacterial Agents; Child; Child, Preschool; Conjunctivitis; Double-Blind Method; Drug Eruptions; Eyelids; Female; Fever; Humans; Incidence; Infant; Infant, Newborn; Inflammation; Intraocular Pressure; Loteprednol Etabonate; Male; Multicenter Studies as Topic; Ophthalmic Solutions; Safety; Tobramycin; Vision, Ocular; Visual Acuity | 2012 |
Comparison of topical tobramycin-dexamethasone with dexamethasone-neomycin-polymyxin and neomycin-polymyxin-gramicidin for control of inflammation after cataract surgery: results of a multicenter, prospective, three-arm, randomized, double-masked, control
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Brazil; Cataract Extraction; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Gramicidin; Humans; Inflammation; Male; Middle Aged; Neomycin; Polymyxins; Postoperative Complications; Prospective Studies; Tobramycin; Treatment Outcome | 2004 |
9 other study(ies) available for tobramycin and Innate Inflammatory Response
| Article | Year |
|---|---|
Acute Infection with a Tobramycin-Induced Small Colony Variant of Staphylococcus aureus Causes Increased Inflammation in the Cystic Fibrosis Rat Lung.
Topics: Animals; Anti-Bacterial Agents; Cystic Fibrosis; Inflammation; Lung; Rats; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2022 |
Mode of bacterial killing affects the inflammatory response and associated organ dysfunctions in a porcine E. coli intensive care sepsis model.
Topics: Animals; Cefuroxime; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Inflammation; Interleukin-10; Interleukin-6; Multiple Organ Failure; Organ Dysfunction Scores; Penicillin-Binding Proteins; Prospective Studies; Sepsis; Swine; Tobramycin; Tumor Necrosis Factor-alpha | 2020 |
Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Survival; Colistin; Cystic Fibrosis; Drug Combinations; Humans; Ibuprofen; Inflammation; Interleukin-8; Lipopolysaccharides; Pseudomonas aeruginosa; Tobramycin | 2021 |
Dynamics of Endotoxin, Inflammatory Variables, and Organ Dysfunction After Treatment With Antibiotics in an Escherichia coli Porcine Intensive Care Sepsis Model.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Disease Models, Animal; Drug Therapy, Combination; Endotoxins; Escherichia coli Infections; Female; Inflammation; Interleukin-6; Leukocyte Count; Male; Multiple Organ Failure; Sepsis; Swine; Tobramycin; Tumor Necrosis Factor-alpha | 2018 |
Co-administration of aqueous ginseng extract with tobramycin stimulates the pro-inflammatory response and promotes the killing of Pseudomonas aeruginosa in the lungs of infected rats.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Load; Body Weight; Chemokines; Culture Media; Cytokines; Inflammation; Lung; Lung Diseases; Male; Organ Size; Panax; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Tobramycin | 2013 |
Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Topics: Administration, Ophthalmic; Animals; Biological Availability; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Excipients; Eye Infections; Female; Gels; Hypromellose Derivatives; Inflammation; Male; Ophthalmic Solutions; Poloxamer; Rabbits; Temperature; Tobramycin | 2016 |
Clinicobacteriological study of chronic dacryocystitis in adults.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Chronic Disease; Ciprofloxacin; Dacryocystitis; Female; Humans; Inflammation; Lacrimal Apparatus; Male; Middle Aged; Pilot Projects; Staphylococcal Infections; Tobramycin | 2008 |
Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Evaluation, Preclinical; Female; Fluorescence Polarization Immunoassay; Inflammation; Mice; Mice, Inbred ICR; Microspheres; Molecular Weight; Muscle, Skeletal; Osteomyelitis; Polyethylene Glycols; Polyglactin 910; Tobramycin | 2003 |
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess.
Topics: Abscess; Animals; DNA Replication; Drug Administration Schedule; Hair Cells, Auditory; Inflammation; Inulin; Kidney; Kidney Diseases; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred F344; Tobramycin | 1988 |